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Abstract 
Zika virus (ZIKV) has recently emerged as a global health concern due to its widespread diffusion and its 
association with severe neurological symptoms and microcephaly in newborns1. However, the molecular 
mechanisms responsible for ZIKV pathogenicity remain largely elusive. Here, we used human neural 
progenitor cells (hNPC) and the neuronal cell line SK-N-BE2 in an integrated proteomics approach to 
characterize cellular responses to viral infection on proteome and phosphoproteome level as well as 
affinity proteomics to identify cellular targets of ZIKV proteins. This approach identified 386 ZIKV-
interacting proteins, unraveling ZIKV-specific and pan-flaviviral activities as well as host factors with 
known functions in neuronal development, retinal defects and infertility. Moreover, our analysis identified 
1,216 phosphosites specifically up- or down-regulated upon ZIKV infection, indicating profound 
modulation of fundamental signaling pathways such as AKT, MAPK/ERK and ATM/ATR providing 
mechanistic insights into the proliferation arrest elicited by ZIKV infection. Functionally, our integrative 
study identifies previously unexplored ZIKV host-dependency factors, providing a comprehensive 
framework for a system-level understanding of ZIKV-induced perturbations at the protein and cellular 
pathway levels.  
 
Main text 
ZIKV, a Flavivirus related to Dengue (DENV), West-Nile (WNV) and Hepatitis C virus (HCV), has a single 
stranded RNA genome of positive polarity, encoding for a polyprotein that is co- and post-translationally 
processed into three structural (capsid, prM, and envelope) and seven nonstructural proteins (NS1-NS2A-
NS2B-NS3-NS4A-NS4B-NS5)2. To comprehensively understand how ZIKV targets and affects neuronal 
cells, we performed an unbiased proteome survey to identify cellular proteins and associated complexes 
interacting with each of the ten ZIKV proteins (isolated from the clinical Asian isolate FSS130253) 
expressed in a human neuroblastoma cell line (SK-N-BE2) (Fig. 1a, Extended Data Fig. 1a). Given the 
complex membrane topology of the polyprotein, we designed each of the viral expression constructs to 
undergo appropriate polypeptide processing and correct insertion into the ER membrane (Extended Data 
Fig. 1a). Except for NS2A, all ZIKV proteins were correctly expressed and processed (Extended Data Fig. 
1b-c). Specificity controls included NS4B of HCV (NS4B-HCV) and Gaussia luciferase. One-step affinity 
purification coupled with Liquid chromatography and Mass spectrometry (AP-LC-MS/MS) followed by 
Bayesian statistical modelling, allowed to identify 386 proteins specifically associating with ZIKV open-
reading frames (ORFs), resulting in 484 high-confident interactions (Fig. 1b, Extended Data Fig. 2 and 
Supplementary Table 1). We identified a high number of previously reported bona fide interactors of 
flavivirus proteins, validating the dataset. ZIKV-NS4B, for instance, associates with several subunits of 
the ATPase (ATP1A1, 1A2, 1A3, 1B and 6V1H), voltage-dependent anion selective channel proteins 
(VDAC1,2,3) and calcium-binding mitochondrial proteins (i.e. SLC25A, SLC38A1) as well as components 
of the cytochrome C oxidase complex (COX15, MT-CO2, NDUFA4), confirming ATP production, calcium 
homeostasis, apoptosis, and mitochondrial respiratory chain, as important targets of diverse flaviviruses4 
(Extended Data Fig. 2). Similarly, mining the Capsid cellular interactome revealed nuclear and nucleolar-
resident proteins such as nucleolin (NCL), nucleolar RNA-dependent helicases of the DDX family, core 
histones (H2A) as well as peroxisomal proteins including PEX19 that have previously been reported as 
cellular targets of DENV and WNV (Fig. 1b and Extended Data Fig. 2)5-7. Most importantly, this analysis 
uncovered host factors not previously associated with flaviviruses and enriched in ER-, mitochondria- and 
nuclear-resident proteins largely reflecting the subcellular localization of the viral protein (Extended Data 
Fig. 2). Furthermore, this dataset revealed a number of proteins linked to neurological diseases or 
development, particularly among the Capsid- and NS4B-specific interactors (Fig. 1b). For instance, 
among the Capsid interactors were LARP7 (involved in telomere stability and mutated in Alazami 
syndrome)8, LYAR (important for maintenance of embryonic stem cells identity)9 and NGDN (a neuronal 
development factor)10 (Ext Data Fig. 4b). Of particular interest are interactors of NS4B, one of the vORFs 
recently suggested to be involved in inhibition of neuronal development via activation of autophagy11. In 
direct comparison with HCV-NS4B, ZIKV-NS4B showed specific enrichment in cellular proteins covering 
functions associated with the whole spectrum of ZIKV-associated pathogenesis ranging from 
neurodegenerative disorders and retinal degeneration (CLN6, BSG), to regulators of neuronal 
differentiation (CEND1, RBFOX2) and axonal dysfunction (CHP1, TMEM41b) (Fig. 1b, Extended Data 
Fig. 2, 3). Ablation or natural mutations of these proteins drive neurological disorders, confirming their 
roles in neuronal development12-17. Co-immunoprecipitation followed by western blotting (Co-IP) verified 
that these proteins specifically associate with arthropod-borne NS4Bs (such as DENV and ZIKV) and not 
NS4B of other flaviviruses such as HCV; with a subset of proteins specifically binding only to ZIKV-NS4B 
(TMEM41b, CEND1, CLN6; Fig. 2a). Furthermore, reciprocal Co-IP also confirmed NS4B association in 
ZIKV-infected cells (Extended Data Fig. 4a). ZIKV-NS4B precipitated particularly well Ceroid-
lipofuscinosis neuronal protein 6 (CLN6), which is associated with a lysosomal storage disease causing 
neurodegenerative late-infantile disorders as well as retinal defects12 (Fig. 2b and Extended Data Fig. 4a). 
Sub-cellular localization analysis of ZIKV-infected or NS4B-transduced primary hNPC indicated profound 
redistribution of CLN6 to sites of viral replication and NS4B, respectively (Figure 4c, d and Extended Data 
Fig. 4d). AP-LC-MS/MS experiments using CLN6 as bait pinpointed binding partners shared between 
NS4B and CLN6 (Extended Data Fig. 4e), such as SLC7A5 (also known as LAT1) – a neutral amino 
acids transporter functioning at the brain blood barrier with involvement in neurogenesis and retina 
homeostasis18. Furthermore, CLN6 associated specifically with mTOR and TELO2, important regulators 
of signaling pathways that have been reported to be affected by ZIKV infection11,19. Altogether, the ZIKV-
vORF interactome in human neuronal cells revealed a multitude of new Flavivirus host binding partners, 
including cellular proteins and signalling pathways components involved in neuronal development.  
 
In patients, during early stages of development, ZIKV predominantly infects neural progenitor cells20,21 
causing microcephaly and other neurodevelopmental injuries. In order to gain insights into ZIKV-induced 
perturbations occurring at the onset of brain development we employed a human induced pluripotent 
stem cell-derived neuronal differentiation model. In the first step we defined the global proteomic changes 
occurring during differentiation of hNPC into neurons22 using LC-MS/MS analysis (Extended Data Fig. 5a, 
b). Importantly, markers of neuronal differentiation such as βIII-tubulin (TUBB3), microtubule-associated 
proteins 2 and 6 (MAP2, MAP6), neuronal cell adhesion molecule 1 (NCAM1), doublecortin (DCX) and 
ELAV-Like RNA Binding Protein 3 (ELAVL3) (Fig. 2c, Supplementary Table 2) were significantly 
upregulated, corroborating the progression of hNPC towards neuronal differentiation. Next, we 
investigated the influence of ectopic expression of ZIKV-NS4B and HCV-NS4B on early neuronal 
differentiation. Notably, ectopic expression of ZIKV-NS4B, but not of HCV-NS4B, during differentiation 
specifically altered the expression of a subset of proteins, many of which particularly relevant for neuronal 
development (Fig. 2e and Extended Data Fig. 5c-d, Supplementary Table 3). For example, a subset of 
factors involved in neuronal differentiation (e.g. MAP2, -6, DPYSL3, -5, CNTN2; Fig. 2d, green squares 
and circles) as well as proteins associated with neurological diseases, including DOK323 and SUMO224, 
were downregulated in ZIKV-NS4B but not HCV-NS4B transduced cells (Fig. 2d,e, Extended Data Fig. 5c 
and Supplementary Table 2). These observations suggest that ZIKV-NS4B perturbs specific 
developmental programs. Similar effects could be seen in proteomic analysis of hNPC infected with ZIKV 
in the presence or absence of differentiation stimuli (Extended Data Fig. 6a). ZIKV infection led to a 
general antiviral response evinced by robust up-regulation of type-I interferon stimulated genes (e.g. 
STAT1, MX1, OAS3, IFIT1 etc.). However, infection also led to specific down-regulation of neuronal 
factors under differentiation conditions (Extended Data Fig. 6b and Supplementary Table 4). Altogether, 
these experiments unveil for the first time the distinct proteomic signatures of ZIKV and ZIKV-NS4B on 
differentiating hNPC, revealing specific targets deregulated during neurogenesis. 
Growing evidence suggests that protein post-translational modifications, especially phosphorylation, play 
a crucial role in controlling and executing the complex and dynamic reorganization of signal-transduction 
pathways upon infections by a broad range of viruses25-29. We therefore used time-resolved 
phosphoproteomics30 to investigate cellular pathway dysregulation upon ZIKV infection. SK-N-BE2-
infected or mock-treated cells were harvested 24, 48 and 72 hours post ZIKV infection and their 
phosphoproteome was quantitatively analyzed by label-free LC-MS/MS. This analysis identified 14,222 
unique phosphosites (localization probability ≥ 0.75; Extended Data Fig. 7a-d), 1,216 of which were 
modulated upon ZIKV infection (Fig. 3a and Supplementary Table 5). Analysis of biological functions 
enriched among the sites specifically affected by ZIKV infection revealed cellular assembly and 
organization, cell-cycle regulation, as well as nervous system (NS) development and neurological 
diseases as significantly modulated (Fig. 3b, Supplementary Table 6). Most importantly, the depth of 
details achieved by this approach allowed us to map specific phosphorylation events along entire cellular 
pathways highlighting modulation of key processes such as ATM, AKT/mTOR and ERK/MAPK signaling 
cascades (Fig. 3c-g, Extended Data Fig. 7, Supplementary Tables 7-8). For instance, we could identify 
profound down-regulation of the AKT-mTOR signaling pathway, as indicated by de-phosphorylation of 
known AKT1 substrates (e.g. DNMT1, TBC1D4, LARP6), mTOR targets (e.g. ANKRD17, LARP1, PATL1, 
EEF2K), the central kinase S6K and its main effector protein S6. Coherently with down-regulation of the 
AKT-mTOR signaling pathway, we also found increased phosphorylation of proteins, such as the 
negative regulator of autophagy DAP, at residues known to inhibit its suppressor effect and consistent 
with the notion that autophagy is induced after ZIKV infection11,31 (Fig. 3d,g, Extended Data Fig. 7f). 
Interestingly, ZIKV infection additionally down-regulated the MAPK/ERK-signaling pathway, since both A-
RAF and ERK2 as well as several substrates of the downstream ERK1/2 Map kinases (EIF4EBP1, 
BAZ1B, TWIST) were significantly de-phosphorylated upon ZIKV infection (Fig. 3c, Supplementary Tables 
5, 8). While modulation of autophagy or the AKT/mTOR pathway has been recently associated with 
ZIKV11, our data now allow to quantitatively map individual phosphorylated residues onto signalling 
pathways on a global scale. In this respect, complex crosstalks between different cellular pathways 
modulated upon ZIKV infection could be identified (Extended Data Fig. 7e). For instance, both ERK1/2 
and mTOR pathways converge on S6K and modulate its phosphorylation status32 (Fig. 3c), suggesting 
multiple possible mechanisms contributing to the observed ZIKV-induced upregulation of autophagy, 
diminished hNPC proliferation and impaired neurogenesis. Noteworthy, we could also observe a massive 
up-regulation of the ATM (ataxia-telangiectasia mutated)/ATR (ATM- and Rad3-Related) DNA-damage 
pathway, as inferred from significantly increased phosphorylation of several substrates of ATR (NPM1, 
CGGBP, GINS2), DNAPK (XRCC4) and downstream effector proteins (H2AFX) as well as proteins 
involved in cell cycle regulation and DNA damage checkpoint (TOP2B, CDK1) (Supplementary Tables 5, 
8). Our data therefore suggest a mechanistic link between the observed ZIKV-induced cell-cycle arrest19 
and p53 activation33, since persistent activation of DNA damage repair pathways in response to ZIKV-
induced mitotic abnormalities (such as multipolar spindle and supernumerary foci19) might lead to cell 
death of neuronal progenitors (Fig. 3c). Most importantly, this analysis sheds light on previously 
unreported ZIKV targets with known functions in neurogenesis. Among these, we noted prominent 
dephosphorylation of proteins such as p38 MAPK and downstream targets (HSP27 and ATF7), MARCKS 
(one of the main PKC substrates) and DPYSL2, whose activation positively modulates neurite outgrowth 
and brain development (Fig. 3f-g)34-38.  
To assess the functional relevance of the host factors newly identified through our orthogonal proteomic 
survey, we selected cellular targets regulated either at the proteome (n=26), phosphoproteome (n=8) or 
interactome (n=21) level by ZIKV. Expression of individual proteins was silenced by shRNA and the 
consequences on virus infection were determined by plaque assay (Fig. 4a, Extended Data Fig. 8a-c and 
Supplementary Table 10). This approach identified 17 host-factors whose silencing significantly reduced 
ZIKV replication as compared to NT controls (Fig. 4a). Besides confirming the essential role for recently 
described cellular factors in ZIKV replication, such as STT3A39, MGGT140 and MSI141, we identified 14 
additional host proteins critically required for ZIKV replication. Among these were proteins whose cellular 
abundance was strongly decreased upon NS4B expression and/or ZIKV infection in differentiating hNPC 
cells (i.e. DOK3, XIRP2, YIPF4 and LMOD3), proteins that changed phosphorylation status upon ZIKV 
infection (LMO7, FXR1 and LARP7) and ZIKV interacting proteins (i.e. Capsid: LARP7 and LYAR; NS4B: 
BSG and CLN6) (Fig. 4a). Importantly, validation experiments confirmed that CEND1, CLN6, CHP1, 
LMOD3, TMEM41b and BSG knockdown resulted in inhibition of ZIKV replication (Fig. 4b, and Extended 
Data Figure 8d, e, f). Moreover, infection of hNPC with two different ZIKV isolates (H/PF/2013 and 
MR766) recruited CLN6 and TMEM41b to sites enriched in dsRNA and NS4B, further corroborating their 
involvement in viral replication (Fig. 4c, d, e). 
 
In this orthogonal proteomic survey we combined quantitative information at the proteome, 
phosphoproteome and interactome levels with publicly available interaction databases in order to get a 
holistic perspective on ZIKV impact in neuronal cells (Extended Data Fig. 9, Supplementary Table 9). Our 
integrated dataset offers the opportunity to pinpoint relationships between cellular proteins that are 
specifically exploited by ZIKV, and allows deducing potential driving mechanisms responsible for 
neurotoxicity. The interactome suggests entry points of hijacked signaling pathways, which could be 
tracked by phosphoproteome changes, while long-term effects accumulate on the proteome level. For 
instance, this orthogonal intersection revealed putative novel links between ZIKV-NS4B and activation of 
DNA damage and mTOR signaling pathways, as exemplified by the identification of CLN6 among the 
NS4B-specific interactors (Fig. 4f). Additionally, these data can be used to infer hotspots targeted by ZIKV 
at multiple levels. For example, the ZIKV host factor LARP7, is a Capsid-specific interactor that is 
additionally hypophosphorylated by ZIKV. Similarly, LMO7 is simultaneously downregulated at the protein 
level and hyperphosphorylated upon virus infection (Fig. 4f).   
In general, our data provide valuable insights into how ZIKV exerts its action on candidate proteins 
previously identified in high-throughput genetic as well as drug-based screens. For instance, a recently 
published FDA-approved drug screen identified among the ZIKV inhibitors Digoxin, an inhibitor of the 
ATP1A1 Na2+/K+, here identified as NS4B-specific interactor. Fingolimod is an inhibitor of the 
Sphingosine1 phosphate receptor – S1PR2, which is persistently hypophosphorylated upon ZIKV-
infection. Finally, Mycophenolic Acid/MPA, an inhibitor of the Inosine-5-monophosphate dehydrogenase 1 
– IMPDH1 was identified as specifically down-regulated protein in ZIKV infected cells42. A CRISPR-based 
screen for ZIKV identified STT3A, an Oligosaccharyltransferase complex subunit, and SSR3, the 
Translocon-associated protein subunit gamma, as important ZIKV host-dependency factors. Both proteins 
are identified here as cellular binders of NS2B-3 and NS4B39. Although some of the ZIKV binding partners 
identified here may associate with orthologues of closely related flaviviruses (e.g. DENV, WNV), their role 
in ZIKV-related pathogenesis might in addition rely on the unique ability of ZIKV to cross the placental 
barrier and reach the developing brain43.  
Our study suggests that ZIKV evolved multiple mechanisms to usurp, exploit or perturb fundamental 
cellular processes, ultimately contributing to the broad spectrum of pathological abnormalities observed in 
humans. In addition, this study provides a rationale resource for streamlining ZIKV-research efforts and 
considering or excluding intracellular pathways for specific therapeutic intervention. 
 
 
 
 
 
 
 
 
 
 
 
Methods 
Cell lines and reagents 
HeLa S3 (CCL-2.2) and Vero E6 cells (CRL-1586) were purchased from ATCC. SK-N-BE2 cells were 
kindly provided by Rüdiger Klein (MPI of Neurobiology, Munich). HEK293 cells were a gift from Andrew 
Bowie (Trinity College, Dublin). Human Neural Progenitor (hNPC) cells were generated as described 
below. All cell lines were tested to be mycoplasma free and their identity verified by STR profiling. Primary 
antibodies used in this study were: rabbit polyclonal anti-CEND1 (1:5000 WB, #ab113076; Abcam), rabbit 
polyclonal anti-RBFOX2 (1:500 WB, #HPA006240; Sigma-Aldrich), rabbit polyclonal anti-CLN6 (1:500 
WB, #SAB4502281; Sigma-Aldrich), rabbit polyclonal anti-CHP1 (1:500 WB; #PA5-29876; Thermo-
Fisher), rabbit polyclonal anti-BSG (1:2000 WB, #HPA036048; Sigma-Aldrich), rabbit polyclonal anti-
TMEM41b (1:250 WB, #HPA014946; Sigma-Aldrich), mouse monoclonal anti-dsRNA J2 (1:400 IFA; 
Scicons), mouse IgG2bκ anti-HA (1:500 IFA; 12CA5; Sigma-Aldrich), rabbit polyclonal anti-DENV NS4B 
(1:100 IFA; 1:500 WB; #GTX124250; Genetex. This antibody cross-reacts with ZIKV-NS4B, as validated 
by immunodetection of ZIKV-NS4B in cells transduced with HA-tagged NS4B or ZIKV-infected cell lysates 
(Extended Data Fig. 4b)). For detection of NS4B and Capsid upon ZIKV infection by western-blotting, the 
rabbit polyclonal anti-ZIKV NS4B and anti-ZIKV Capsid (1:1000 WB, #GTX133311; and 1:1000, 
#GTX133317 Genetex) were used. For detection of phosphorylated and total protein abundance by WB, 
mouse monoclonal anti-gammaH2Ax (#ab22551; Abcam) and the following rabbit monoclonal antibodies 
were used (Cell Signalling Technology): anti-MARCKS (#D88D11) and anti-phospho-MARCKS (#D13E4), 
rabbit monoclonal anti-mTOR (#7C10) and anti-phospho-mTOR (#D9C2), p38-MAPK (#D13E1) and anti-
phospho-p38 MAPK (#D3F9), S6 ribosomal protein (#5G10) and anti-phospho S6 (#D57.2.2E). Where 
indicated, to increase the basal phosphorylation of certain cellular proteins, 12-O-tetra-decanoylphorbol-
13-acetate (TPA, Cell Signalling Technologies) or DMSO, were added to the culture medium (32 nM) 15 
minutes before harvesting cell lysates for WB analysis. For characterization of hNPC by 
immunofluorescence, the following antibodies were used: mouse anti-GFAP (#G3893; Sigma-Aldrich), rat 
anti-Ki67 (#14-5698; EBioscience), mouse anti-MAP2 (#M4403, clone HM-2; Sigma-Aldrich), mouse anti-
Nestin (#MAB5326, clone 10C2; Millipore), rabbit anti-Sox2 (#ab137385, Abcam).   
 
Generation, maintenance and differentiation of human neural progenitor cells (hNPCs) 
Human induced pluripotent stem cells (iPSC) generated from healthy patient fibroblasts were maintained 
in mTeSRTM 1 media (STEMCELL Technologies) on Geltrex (ThermoFischer Scientific) plates in the 
absence of feeders. The iPSC were regularly confirmed to be mycoplasma-negative. The protocol used 
for derivation of human neural progenitor cells (hNPC) has been previously described44 with 
modifications. Briefly, iPSC colonies were harvested with a cell scraper to ensure relatively big colonies 
remain and cultured in suspension to form embroid bodies (EBs) in DMEM/F-12, 0.5% N2 supplement 
(Gibco), 5μM Dorsomorphin (Sigma-Aldrich), 10μM SB431542 (Sigma-Aldrich) and 10 μM Rho-
associated kinase inhibitor (ROCK) (Y-27632, StemCell Technologies). EB were grown for 5 days with 
media changed every other day before gentle trituration and attachment on poly-ornithine/laminin coated 
dishes in NPC media consisting of DMEM/F-12, 0.5% N2, 1% B27 supplement with 10 ng/ml bFGF 
(Peprotech 100-18B-50) and 10 μM ROCK. Three to four days after EB plating, neural rosettes were 
manually isolated, dissociated mechanically to single cells and plated on fresh poly-ornithine/laminin 
coated dishes in NPC media with 10 μM ROCK inhibitor. On the next day, the media was changed to 
NPC media without ROCK and NPCs were propagated for up to 12 passages by splitting with accutase 
when 70-80% confluency was reached. For short-term differentiation experiments (Fig. 3c, d, e and 
Extended Data Fig. 4), 2x105 cells were seeded on 6-well plates, transduced with empty lentiviruses (NT), 
lentiviruses expressing HCV- or ZIKV-NS4B or infected with 0.01 MOI of ZIKV H/PF/2013. Forty-height 
hours later differentiation was induced for 5 days by growth factor withdrawal and addition of 10 µM 
ROCK inhibitor, while undifferentiated cells were kept in NPC media in the presence of bFGF. In both 
cases media was replaced every other day. Cell pellets were harvested, snap-frozen and processed for 
LC-MS/MS analysis as described below.  
 
Virus strains, virus stocks preparation and generation of lentiviruses 
ZIKV strains H/PF/2013 and MR766 were obtained from the European Virus Archive (EVAg, France). 
Virus stocks were passaged once on VeroE6 cells and virus-containing cell culture supernatants or 
conditioned medium from uninfected cells were harvested from day 3 to 8 post-infection. Supernatants 
were filtered through a 0.45 μM pore-size filter and stored at -70 °C. Titers of infectious virus were 
determined by plaque assay as previously described (see below). For infection of hNPCs, virus stocks 
were diluted in hNPC medium and cells were inoculated for 2 h at 37°C. Inocula were removed and fresh 
hNPC medium (basal or differentiation) was added. Mock cells were inoculated with equal amounts of 
conditioned medium.  
For generation of lentiviruses expressing the individual HA-tagged ZIKV viral proteins or FLAG-tagged 
host proteins, synthetic cDNAs (sequences based on recently described recombinant ZIKV strain 
FSS13025, Asian lineage3) were obtained in pUDC57 vectors and the fusion gene inserted into the 
lentiviral pWPI expression plasmid. Lentivirus expressing the HA-tagged NS4B of Hepatitis C virus was 
previously described45. Lentivirus stocks were produced and titrated as described4. Nucleotide sequences 
of each construct are available upon request. 
 
Lentiviral shRNA Library Production and shRNA screen  
From the MISSION TRC lentiviral library (Sigma-Aldrich), 54 MS hits and 4 controls were selected and 
shRNA were produced as follows. Two different shRNA-expressing lentiviruses per gene (116 shRNAs in 
total; Supplementary Table 10) were produced individually in HEK 293T cells (8x105) that were plated one 
day prior to transfection. Transfections were performed as previously described4 using packaging 
plasmids psPAX2 and pMD-VSV-G (kindly provided by Dr. Didier Trono) and shRNA-encoding pLKO-
puro plasmids. Viruses were collected at 48 and 72h post-transfection, clarified by centrifugation and 
pooled prior to freezing. Controls included non-targeting shRNA-encoding plasmid SHC001 and SHC002 
(NT1 and NT2) as well as known virus restriction factors ATP6V0C and Musashi1. For quality control 
purposes, approximately 25% of random samples were used to measure lentiviral titers. For screening 
purposes, 10,000 SK-N-BE2 cells per well were seeded in 96-well plates in 90 μl of complete DMEM and 
24 hours later cells were transduced with 30ul of each lentivirus (MOI≈3) in triplicate wells/replica and 
three independent biological replicates). Three days later cells were infected with 0.1 MOI of ZIKV 
H/PF/2013, and 48 h.p.i. cell supernatants were used for titration by PFU assay. Cell Viability was 
measured by a Resazurin-based cell-viability assay, on plates which were transduced with shRNAs in 
parallel but were not ZIKV-infected. In brief, 50 μg/ml resazurin was added to each well of a 96-well plate 
and incubated for 30 min at 37 °C, followed by measurement of fluorescence (535/590 nm) using an 
Infinite 200 PRO series micro plate reader (Tecan). The normalization for the virus titers and fluorescence 
measurements were performed in 2 steps. First, the measurements in each replicate experiment were 
adjusted by the median factor of the replicate (the median of Xg,i/median(Xg,1, Xg,2, Xg,3) across all the 
shRNAs (g=1,2,...,116), where Xg,i is the titer of g-th shRNA in i-th replicate). Then the adjusted 
measurements were normalized, such that the average signal of Non-targeting controls was 100%. The 
following criteria were applied to select hits: ≥50% decrease in median viral titers with two shRNAs or 
≥75% if only one shRNA was efficient; cell viability ≥75% of NT controls. Validation experiments on 
selected shRNAs (Fig.4b, and Ext Data Figure 8c-d) were performed on 24-well plates using the same 
overall protocol. 
 
Virus titration by plaque assay 
Confluent monolayers of VeroE6 cells were infected with serial 10-fold dilutions of virus supernatants for 
2 h at 37 °C. Inoculum was removed and replaced with serum-free MEM (Gibco, Life Technologies) 
containing 1.5% carboxymethylcellulose (Sigma-Aldrich). Four days post-infection, cells were fixed for 2 h 
at room temperature with formaldehyde directly added to the medium to a final concentration of 5%. Fixed 
cells were washed extensively with water before being stained with H2O containing 1% crystal violet and 
10% ethanol for 30 min. After rinsing with water, the number of plaques was counted and virus titers were 
calculated. 
 
Deep proteomes and phosphoproteome sample preparation 
For proteomic and phosphoproteomic analysis, SK-N-BE2 cells (107 cells/biological replicate/condition; 4 
biological replicates/condition), were mock-infected or infected with ZIKV H/PF/2013 at an MOI of 3. Cell 
pellets were harvested after 24, 48 and 72 hours, lysed in 1mL of lysis buffer (10 mM Tris-HCl [pH 7.5], 
4% SDS, and 0.05 mM DTT supplemented with complete protease and phosphatase inhibitor cocktails 
[Roche]), boiled 10’ at 98 °C, and sonicated (4°C for 15 min, or until a homogeneous suspension was 
formed). Clarified protein lysates were precipitated with acetone, and normalized protein mixtures 
resuspended in 500 μL TFE digestion buffer. Protein digestion was performed by adding 1:100 
(protein:enzyme) trypsin and LysC with rapid agitation (2,000 rpm) overnight at 37°C. An aliquot of the 
peptide mixtures was used for determination of the total proteome (10%) as previously described46 while 
the remaining peptide mixture (90%) was processed for phosphopeptide enrichment using the EasyPhos 
protocol30. For proteomic analysis of primary cells, hNPC were seeded in 6-well plates (2x105 cells/well) 
and either mock-infected, infected with 0.01 MOI of ZIKV or transduced with lentiviruses expressing HA-
tagged ZIKV-NS4B or HCV-NS4B (MOI=3). Two days after infection or lentivirus transduction, cells were 
left in hNPC proliferation media (undiff.) or neuronal differentiation was initiated by culturing the cells in 
hNPC differentiation media (diff.). Five days later cell pellets were collected and processed for label-free 
LC-MS/MS analysis as described before46. Each condition was performed in quadruplicate biological 
replicates. 
 
Deep proteome and phosphoproteome LC-MS/MS analysis and data processing 
Peptide mixtures were separated on a 50 cm reversed-phase column (diameter of 75 μm packed in-
house with ReproSil-Pur C18-AQ 1.9 μm resin [Dr. Maisch GmbH]) as previously described47. 
Raw MS files were processed within the MaxQuant environment (version 1.5.7) using the integrated 
Andromeda search engine with FDR ≤ 0.01 at the protein, peptide, and modification level. Proteome and 
phosphoproteome files were assigned to separate search parameter groups. The search included fixed 
modifications for carbamidomethyl (C) and variable modifications for oxidized methionine (M), acetylation 
(protein N-term), and phospho (STY) for phosphoproteome files. Peptides with at least six amino acids 
were considered for identification, and “match between runs” was enabled with a matching time window 
of 0.7 min to transfer MS1 identifications between runs. Peptides and proteins were identified using a 
UniProt FASTA database from human (UniprotKB release 2015_08 including isoforms and unreviewed 
sequences) and ZIKV virus polyprotein corresponding to the H/PF/2013 strain (NCBI GenBank 
KJ776791.2; individual viral cleavage products were manually annotated).  
 
Sample preparation for affinity-purification of ZIKV proteins and cellular proteins 
For the determination of the ZIKV interactome, four independent affinity purifications were performed for 
each ZIKV HA-tagged viral protein. SK-N-BE2 cells were transduced with an MOI of 3 of each lentivirus 
(8x106 cells/dish) and 72 hours later cells were scraped in 1 ml of Lysis Buffer (50 mM Tris pH=8, 150 mM 
NaCl, 0.5% NP-40, cOmplete protease inhibitor cocktail, Roche) and HA-affinity purifications performed 
as described before48. Briefly, clarified cell lysates were incubate with anti-HA-specific beads for 3h at 
4°C, and non-specifically bound proteins removed by three washes with Lysis buffer and 5 washes with 
Washing Buffer (50 mM Tris pH=8, 150 mM NaCl).  Bound proteins were denatured by incubation in 20 µl 
Guanidinium Chloride buffer (600 mM GdmCl, 1mM TCEP, 4mM CAA, 100 mM Tris/HCl pH 8). After 
digestion with 1 µg LysC (WAKO Chemicals USA) at room temperature for 3 h, the suspension was 
diluted in 100 mM Tris/HCl (pH 8), and the protein solution was digested with trypsin (Promega) overnight 
at room temperature. Peptides were purified on stage tips with three C18 Empore filter discs (3M) and 
analyzed by mass spectrometry as described previously49. For the analysis of CLN6 and other host 
factors interactome, SK-N-BE2 cells were transduced with the corresponding FLAG-tagged lentiviruses 
and 72 hours later cell lysates were processed as described above, using agarose anti-FLAG M2 beads 
(Sigma-Aldrich).   
 
Data processing of AP-LC-MS/MS samples 
Raw mass-spectrometry data were processed with MaxQuant (software version 1.5.3) using the built-in 
Andromeda search engine to search against the human proteome (UniprotKB release 2015_08 including 
isoforms and unreviewed sequences) containing forward and reverse sequences plus ZIKV virus 
polyprotein (ZIKV strain FSS13025, Asian lineage3 NCBI GenBank KU955593.1 with individual viral 
cleavage products manually annotated), Gaussia luciferase (Q9BLZ2), NS4B of Hepatitis C virus 
(E7ELX2) sequences, and the label-free quantitation algorithm as described previously50. In MaxQuant, 
carbamidomethylation was set as fixed and methionine oxidation and N-acetylation as variable 
modifications, using an initial mass tolerance of 6 ppm for the precursor ion and 0.5 Da for the fragment 
ions. Search results were filtered with a false discovery rate (FDR) of 0.01 for peptide and protein 
identifications. 
 
Statistical analysis of MS data 
MaxQuant output files (proteinGroups.txt and “Phospho (STY) Sites.txt” for proteome and 
phosphoproteome data, respectively) were processed by a combination of in-house R (version 3.3), Julia 
(version 0.5) and Stan (version 2.14) scripts. 
To account for the variation in the analyzed biological sample amounts and MS performance, we have 
inferred the normalizing multipliers for each MS run so that the normalized LFQ values of the 
representative set of proteins (ca. 500 randomly selected from the ones quantified in most of the 
normalized samples) do not change between the samples. First, this procedure was applied to normalize 
replicate MS runs within each condition, and then the normalization multipliers were further adjusted to 
normalize the conditions between each other. For the analysis of proteome changes the LFQ intensities 
were fit to a generalized linear Bayesian statistical model for each protein group (raw intensities of each 
phosphosite for phosphoproteome data) individually. The model employed horseshoe priors for the model 
effects, and natural logarithm as a linking function for protein intensities. Additional parameters with 
horseshoe priors were introduced to model the biological variation within replicate samples. The MS 
measurements were set to follow Laplace distribution. Technical MS runs from both LTQ-Orbitrap XL and 
Orbitrap Q Exactive HF were used to estimate the signal-to-noise ratio and sensitivity of protein 
quantitation across the whole dynamic range of protein intensities. We used the obtained technical 
variation models to define the scale parameter of Laplace distribution for each individual MS 
measurement as well as scale and location parameters of the logistic distribution for missing MS 
measurements. The experimental design matrices and global horseshoe prior parameters for GLM 
models used to fit each individual data set were defined as follows (using R GLM formula language): 
 
Data set R GLM formula 
τ1 Horseshoe 
Prior Parameter 
for Model Effects 
τ2 Horseshoe Prior 
Parameter for 
Biological Variation 
hNPC proteome 
log(intensity) ~ 1 + 
differentiation + treatment + 
differentiation:treatment 
1.0 0.25 
SKN proteome and 
phosphoproteome 
log(intensity) ~ 1 + after_24h + 
after_48h + treatment + 
treatment:(after_24h + after_48h) 
2.0 (proteome) 
1.0 (phosphosites) 
0.1 (proteome) 
0.25 (phosphosites) 
ZIKV AP-LC-
MS/MS log(intensity) ~ 1 + bait 1.0 0.3 
ZIKV host targets 
AP-LC-MS/MS log(intensity) ~ 1 + bait 2.0 0.1 
 
The posterior distributions of model parameters were inferred using Hamiltonian Markov Chain Monte 
Carlo (MCMC) method (Stan version 2.14), employing 8 parallel MCMC chains, 2000 warmup and 2000 
sampling iterations taking every 4th sample from each chain. The statistical significance (p-value) of a 
hypothesis that given model variable X is positive, i.e. probability that a random sample of its posterior 
distribution would be non-positive (P(X ≤ 0)), was calculated by approximating the posterior distribution 
from MCMC samples using Gaussian kernel with Silverman’s rule-of-thumb bandwidth. For the X≠0 
hypothesis the p-value was defined as min(P(X ≤ 0), P(X ≥ 0)). P-value ≤ 0.01 and |median (log2 fold-
change)| ≥ 1 criteria were used for reporting significantly regulated proteins and phosphosites 
(Supplementary Tables 2, 5 and 9). 
To filter for specific AP-MS interactions, the inferred posterior distributions of protein intensities in each 
viral bait of ZIKV AP-MS dataset was compared with the average distribution of the same protein in all 
other baits excluding Capsid protein (due to its highly hydrophobic character and multiple subcellular 
localizations). The interaction was considered specific, if one-sided p-value (calculated as described 
above) was below 5×10-5 for Capsid bait (since there were no other baits with the same biochemical 
properties) and 5×10-2 for the other baits, and median protein enrichment against the background was 
more than 5.56-fold (=22.5) for high-confident and 2-fold for the lower-confidence set of ZIKV protein 
interactions. The same filtering strategy was applied to AP-MS experiments of selected host targets; the 
p-value cutoff was set 0.02 and log2 Fold-change ≥1.5. For networks representation, sub-cellular 
localization of cellular proteins was extracted from Gene Ontology (Version 2016-Sep-21). 
 
Datasets merging 
The integration of all AP-MS, proteomic and phosphoproteomic data was done by matching protein 
groups of individual data sets to each other using in-house scripts. The protein groups were matched if 
they shared a common protein accession code (“Majority Protein ACs” column in MaxQuant output). In 
ambiguous situations (e.g. one protein group of dataset A shares different protein sequences with several 
protein groups of data set B) the priority was given to the reviewed protein sequences and canonical 
isoforms. 
 
Integrating published protein-protein interactions, kinase-substrate relations and regulatory sites 
data 
For overlaying our data with published protein-protein interactions we used IntAct interactions database 
(version 2017.04.08), IntAct complexes collection (version 2017.04.08) and CORUM protein complexes 
database (version 2017.03.15). The interaction (physical association) was included if both interacting 
partners were significantly enriched in the same ZIKV bait. For published AP-MS interactions we 
additionally required that one of the interacting partners was a bait. To integrate AP-MS datasets with 
proteomic and phosphoproteomic screens, only published direct interactions (including kinase–substrate 
relationships) were considered. 
For phosphoproteomic analysis kinase-substrate relations and regulatory sites were extracted from 
PhosphositePlus51 (kinase_substrate_dataset from Mar 21 2017 and regulatory_sites from Apr 18 2017, 
respectively). 
 
Ingenuity pathway analysis 
Proteome and phosphoproteome changes along with unchanged proteins or sites, respectively, were 
submitted to the IPA core analysis. The following cut-offs were set for differentially-expressed proteins: p- 
value ≤ 0.01 and |log2 (fold-change)| ≥ 1. Ingenuity knowledge base was used as reference data-set, 
while only experimentally observed findings were used for confidence filtering. No filters were applied at 
the level of species, tissues or cell lines. Input datasets were used for the functional analysis to identify 
biological functions and canonical pathways that were most significant. Fisher’s exact test was used to 
calculate p-values. Biological functions or pathways were considered significant for p-values ≤ 0.05.  
 
Co-immunoprecipitation assays 
For validation of ZIKV-NS4B interacting proteins, SK-N-BE2 cells were seeded into 15-cm2 dishes (8x106 
cells/dish), transduced with lentiviruses expressing ZIKV or HCV HA-tagged viral proteins or conditioned 
cell culture media. Seventy-two hours post-transduction, cell monolayers were scraped into 1 ml lysis 
buffer (50 mM Tris-HCl [pH 8.0], 0.5% NP-40, 150 mM NaCl and protease inhibitor cocktail (cOmplete, 
Roche), and clarified lysates processed for immunoprecipitation as described above. Eluted proteins were 
further analyzed by western blot as specified in the figure legends. For reciprocal co-immunoprecipitation 
experiments, SK-N-BE2 cells were transduced with lentiviruses expressing each FLAG-tagged host 
protein and three days later infected with ZIKV at an MOI of 3. Seventy-two hours post-infection, cell 
monolayers were processed for immunoprecipitation with anti-FLAG M2 agarose beads (Sigma-Aldrich) 
as described above. 
 
Immunofluorescence analysis 
Human Neural progenitor cells (105 cells/well) seeded on poly-ornithine/laminin coated glass slides were 
transduced with lentiviruses (MOI=3) expressing FLAG-tagged proteins or empty control for 1h at 37°C. 
The next day media was changed and 48 h post-transduction cells were infected with ZIKV MR766 or 
H/PF/2013 at an MOI of 5 for 1h at 37°C. After 24h cells were fixed with 4% PFA, permeabilized with 
0.1% (vol/vol) Triton X-100 in PBS and unspecific binding sites blocked with PBS containing 5% BSA for 
1h at RT, and subjected to immunofluorescence staining using anti-FLAG antibody, anti-DENV NS4B or 
J2 anti-dsRNA. Secondary staining was performed with donkey anti-mouse Alexa568-conjugated and 
goat anti-rabbit Alexa 488-conjugated antibodies. Nuclear DNA was stained with 4′,6-diamidino-2-
phenylindole (DAPI) (Molecular Probes). Coverslips were mounted in Fluoromount-G mounting medium 
(Southern Biotechnology Associates). Fluorescence images were acquired with a Leica SP8 inverted 
confocal microscope using a 63x Plan-Apo N.A. 1.4 objective. Image analysis was performed using FIJI 
(http://fiji.sc/wiki/index.php/Fiji)52 and Pearson´s correlation coefficients were calculated using Coloc2 
plugin.  
 
Accession numbers 
UniprotKB accession codes of all protein groups and proteins identified by Mass Spectrometry are 
provided in each respective Supplementary Table and were extracted from UniprotKB (Human; release 
2015_08 including isoforms and unreviewed sequences). cDNA sequences corresponding to individual 
ZIKV open-reading frames used for generation of ZIKV lentivirus library (KU955593.1) or related to the 
wild-type ZIKV H/PF/2013 strain (KJ776791.2) were extracted from GenBank. Protein sequences of 
Gaussia luciferase (E7ELX2) and Hepatitis C virus NS4B (Q9BLZ2) were extracted from UniprotKB.  
 Data availability 
The MS-based proteomics data were deposited at the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the data set identifier 
XXXXX [raw mass-spectrometry files will be deposited on publicly accessible databases at a later stage]. 
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Figures and Figure Legends 
 
Figure 1 – A ZIKV-host protein-protein interaction network in neuronal cells 
 (a) Affinity-purification of ZIKV proteins and interactome generation strategy. (b) Network representation 
of the high-confident ZIKV-host interactome in SK-N-BE2 cells. There are 8 ZIKV bait proteins (red 
squared nodes) and 386 interacting host proteins (ellipse nodes) (All baits: Log2(Fold-change) ≥ 2.5; p-
value ≤ 0.05; Capsid: Log2(Fold-change) ≥ 2.5; p-value ≤ 5×10-5). Interactions of ZIKV and host proteins 
are indicated by black lines. Published physical associations of the host proteins are indicated by dotted 
grey lines. Subcellular localization (color of nodes) of host protein is taken from Gene Ontology. Proteins 
with known functions in neurogenesis or neurological diseases are circled in pink. 
 
 
 
 
 
 
 
 Figure 2 – Validation of NS4B interacting proteins and impact of ZIKV and NS4B on hNPC 
proteome upon differentiation  
(a) Co-immunoprecipitation of ZIKV-NS4B-HA with endogenous host proteins. Cell lysates of SK-N-BE2 
cells transduced with empty lentiviruses (NT) or lentivirus-expressing HA-tagged HCV-, DENV- or ZIKV-
NS4B proteins were used for HA-immunoaffinity purification and probed with the indicated antibodies. 
Representative experiment of three is shown. (b) Reciprocal co-immunoprecipitation of NS4B with FLAG-
tagged CLN6. SK-N-BE2 cells transiently transduced with empty lentiviruses (NT) or lentivirus-expressing 
FLAG-tagged CLN6 were infected with ZIKV (H/PF/2013) and FLAG-immunoprecipitated proteins probed 
with NS4B-specific antibodies. Representative experiment of three is shown. (c) Comparative proteomic 
analysis of differentiated hNPC that were left untreated (undifferentiated) or differentiated for 5 days in the 
presence of ROCK inhibitor. Their global proteome was analyzed by quantitative LC-MS/MS. Significantly 
up- or down-regulated proteins (p-value ≤ 0.01; |Log2(Fold-change)| ≥ 1) are shown in orange and blue, 
respectively; highlighted proteins are known markers of neuronal differentiation. (d) Impact of ZIKV-NS4B 
on differentiated and undifferentiated hNPC. hNPC were transduced with ZIKV- or HCV-NS4B and 
cultured as described above. The scatter plot displays ZIKV-NS4B specific changes (compared to HCV-
NS4B). Proteins non-significantly changing are shown as small grey circles; proteins specifically 
modulated by ZIKV-NS4B are shown as large circles or squares. Color codes refer to functional 
annotations; squares indicate proteins significantly modulated by ZIKV-NS4B which are specifically up- or 
down-regulated during differentiation as in (c). (e) Protein levels of cellular factors differentially modulated 
upon hNPC differentiation and ZIKV-NS4B-transduction. Ratios of protein abundance in naïve hNPC 
(differentiated/undifferentiated), differentiated hNPC (ZIKV-NS4B/HCV-NS4B) or undifferentiated hNPC 
(ZIKV-NS4B/HCV-NS4B). Colored squares indicate functional annotations as in (d), while up- or down- 
regulated proteins are displayed in shades of blue or green, respectively. All significant changes are 
indicated by black circles; sizes correspond to indicated p-values.  
  
 
 Figure 3 – Global phosphoproteomic profiling of ZIKV-infected cells  
SK-N-BE2 cells were either mock-infected or infected with ZIKV (MOI=3) and ZIKV-specific 
phosphoproteomic changes at different time points were analyzed by LC-MS/MS. (a) Total number of up- 
or down-regulated class I phosphosites significantly regulated by ZIKV infection 24, 48 and 72 hours post-
infection (p-value ≤ 0.01; |Log2 (Fold-change)| ≥ 1). (b) Biological functions and (c) canonical pathways 
modulated by ZIKV infection (IPA, Fisher’s exact test p-value <0.05) (S – signaling; R – regulation; P – 
pathway); (d, e) Cellular lysates of SK-N-BE2 cells mock-infected or infected with ZIKV at different time 
points were probed with phospho- or virus-specific antibodies as specified on the right. Where indicated, 
samples were treated with TPA (32 nM) 15´ before lysis. (g) Selected cellular pathways perturbed by 
ZIKV showing significantly up- or down-regulated phosphosites. Colors of protein nodes indicate 
measured (Log2 (fold-change) of strongest phosphosite change) or inferred regulation of the proteins 
central to canonical pathways and/or their substrates. Individual phosphosites are shown next to the 
corresponding molecules (colors indicate the highest Log2(fold-change) over time). Newly identified 
phosphosites are presented as circles, known phosphosites are shown as squares, while regulatory sites 
are marked with framed squares. Arrows signify positive regulation of downstream proteins, while blunt-
ended lines – negative regulation. 
 
 
 
 
 Figure 4 – shRNA screen identifies novel ZIKV host-dependency factors  
(a) SK-N-BE2 cells were transduced with individual shRNAs targeting genes modulated by ZIKV at the 
proteomic or phosphoproteomics level, or specifically bound by ZIKV viral proteins, and ZIKV replication 
measured by PFU assay. Results are presented as heat map and were normalized according to cells 
treated with non-targeting (NT) shRNA. NT controls and shRNAs targeting ATP6V0C and MSI1 are 
highlighted with grey circles, and served as internal controls for lentiviral transduction and inhibition of 
virus replication, respectively. shRNAs exerting cytotoxic effects are indicated by red squares (normalized 
median cell viability < 75% of NT-controls). Results from three independent experiments for each shRNA 
are shown in each row. The genes are ordered by the average rank of median fold-change. The following 
criteria were applied to select hits (highlighted with green circles): ≥50% decrease in viral replication with 
both shRNAs each, or ≥75% with any shRNA. (b) Validation of silencing efficiency and gene knock-down 
effects on ZIKV replication on selected host factors from (a). Data are mean and s.d. of quadruplicate 
infections. Asterisks indicate significance to NT control (student t-test; p-value≤0.001). (c, d, e) hNPC 
cells were transduced with CLN6 or TMEM41b-expressing lentiviruses (MOI=3) and mock-infected 
(mock) or infected with ZIKV H/PF/2013 or MR766 (MOI=5). Fixed cells were immunostained 24h later for 
dsRNA, ZIKV-NS4B and FLAG-tagged proteins as indicated. Boxed areas are enlarged in upper-right 
panels. Scale bar represents 10 µm. Graphs on the right-hand side of each panel display the mean and 
standard deviation of Pearson’s correlation coefficients, each dots represent 1 cell. (f) Intersection of 
ZIKV interactome, proteome and phosphoproteome data sets highlighting characteristic proteins 
perturbed at multiple levels. ZIKV proteins (yellow boxes) interact with host proteins (beige area), 
potentially affecting their normal interactions (orange). ZIKV infection perturbs phosphorylation (green) of 
its host targets (e.g. LARP7) and along signaling pathways (EEF2K and S6K via CLN6-mTOR-TELO2; or 
MAP2 via MARK1/2/3). Protein levels (blue) are also affected and carry, among the others, signatures of 
ZIKV-induced changes to vesicle transport (YIF1A) and neuronal differentiation pathways (MAP2). 
Protein interactions measured in this study are shown by solid arrows; grey dotted arrows represent 
published interactions. The numbers correspond to proteins significantly changed in a given data set or 
data sets intersection. 
 
 
 
 
 
 
 
 
Extended Data Figure Legends 
 
Extended Data Figure 1 - Design rationale, expression and sub-cellular localization of HA-tagged 
ZIKV proteins. 
(a) Schematic representation of ZIKV HA-tagged viral proteins and controls used in this study. The full-
length ZIKV genome is shown at the top, with the 5’ and 3’ NTRs depicted with their putative secondary 
structures. Polyprotein cleavage products are separated by vertical lines and labeled as specified. The 
individual open reading frames (ORFs) of each ZIKV proteins were fused with an HA epitope either at 
their N- or C-termini as depicted. Numbers above each sequence refer to the nucleotide sequence of the 
ZIKV isolate FSS13025 used as reference (GeneBank: KU955593.1). To ensure the correct sub-cellular 
localization and protein topology, the sequence of the Capsid anchor (Canch), the transmbembrane domain 
of prM (prMTM) and the transmembrane domain of Envelope (ETM) were fused at the N-termini of 
prMembrane, Envelope and NS1, respectively. Additionally, given the complex topology of NS2A, the 
ETM, and a fusion protein encoding the first and the last 50 aminoacids of NS1 was fused at its N-
terminus. As additional controls, an empty pWPI-lentiviral vector (NT), or HA-tagged non-structural protein 
4B of Hepatitis C virus (NS4B-HCV) and Gaussia luciferase (G. luciferase) were included to monitor for 
non-specific binding to the anti-HA beads as well as organelle-dependent enrichment artifacts in AP-
MS/MS analysis. (b) Intracellular levels of ZIKV proteins in lentivirus-transduced SK-N-BE2 cells. SK-N-
BE2 cells were transduced with lentiviruses encoding for each ZIKV protein at an MOI of 3, and seventy-
two hours later cell lysates clarified by centrifugation were used for western-blotting against HA and -
actin. Numbers on the left refer to molecular weight standards given in kDa. Asterisks mark protein 
expressed to a lower level, which can be observed upon longer exposure of the membrane. Note that c-
terminally tagged NS2A and n-terminally tagged NS2B-3 could not be detected, while c-terminally tagged 
NS2B-3 fusion protein was expressed at the expected molecular weight, and was therefore used for 
further experiments in this study. The bottom lane indicates the predicted molecular weight of each viral 
protein in kDa. (c) Subcellular localization of ZIKV proteins in lentivirus-transduced SK-N-BE2 cells. SK-
N-BE2 cells were seeded in 24-well plates and transduced as described above. Seventy-two hours post-
transduction viral proteins were detected using rabbit anti-HA antibody and Alexa-fluor488 conjugated 
secondary antibody and imaged by confocal microscopy.  Scale bar, 10 µm. 
 
 
 Extended Data Figure 2 - Volcano plots of individual ZIKV-interacting proteins.  
Volcano plots of label-free Affinity-Purification (AP) LC-MS/MS of individual ZIKV proteins. Each volcano 
plot displays all identified proteins (median log2 fold-change of bait-specific protein enrichment in 
comparison to the background plotted against the corresponding −log10 P-value). Dotted grey lines 
represent the log2 fold-change and P value cut-offs used. High-confident interactors (log2 (Fold-
change) ≥ 2.5, p-value ≤ 0.01) are labelled according to their sub-cellular localization. In case of Capsid, 
due to its highly hydrophobic character and multiple subcellular localizations, more stringent P-value cut-
off was used (p-value ≤ 5x10-5) and ribosomal proteins were not individually labelled. The respective viral 
bait of each AP is shown in black, black circles represent known DENV target proteins while proteins with 
roles in neurogenesis, neurodegenerative diseases or infertility are labelled in red.  
 
 
  
Extended Data Figure 3 - Volcano plots of ZIKV-NS4B and HCV-NS4B-interacting proteins.  
Volcano plot comparing the specificity of protein enrichment in ZIKV-NS4B versus HCV-NS4B AP 
(median log2 fold-change plotted against −log10 p-value for ZIKV-NS4B versus HCV-NS4B). Specific 
NS4B-interacting proteins are labelled as described in Extended Data Figure 2. Previously reported 
interactors of HCV-NS4B, or the ZIKV closely-related DENV-NS4B are shown in blue and green, 
respectively.  
 Extended Data Figure 4 - Validation of NS4B interacting proteins upon ZIKV infection.  
(a) Reciprocal co-immunoprecipitation of NS4B with FLAG-tagged host factors. SK-N-BE2 cells 
transiently transduced with empty lentiviruses (NT) or lentiviruses expressing FLAG-tagged CEND1, 
CLN6, TMEM41b, RBFOX2 and CHP1 were mock-infected or infected with ZIKV H/PF/2013 (MOI=1) and 
three days later FLAG-immunoprecipitated proteins probed with ZIKV NS4B-specific antibody. The 
bottom lane indicates the predicted molecular weights of each viral protein in kDa. Representative 
experiment of three is shown. (b) Validation of anti-DENV-NS4B-specific antibody for immunodetection of 
ZIKV-NS4B. SK-N-BE2 cells were transiently transduced with empty lentiviruses (NT) or lentiviruses 
expressing HCV-NS4B-HA, DENV-NS4B or ZIKV-NS4B-HA, and 72 hours later probed consecutively 
with mouse anti-HA (left panel) or rabbit anti-DENV-NS4B specific antibodies. ZIKV-infected SK-N-BE2 
cell lysates, shown on the right-end side, were included as control. Asterisks indicate unspecific bands. 
(c) Reciprocal co-immunoprecipitation of Capsid with FLAG-tagged host factors. SK-N-BE2 cells 
transiently transduced with empty lentiviruses (NT) or lentiviruses expressing FLAG-tagged SMN1, LYAR, 
LARP7 and NGDN were infected as described above and FLAG-immunoprecipitated proteins probed with 
ZIKV Capsid-specific antibody. Representative experiment of two is shown. (d) hNPC were transduced 
with lentiviruses expressing Flag-tagged CLN6 alone (mock) or co-transduced with lentiviruses 
expressing HCV-NS4B-HA or ZIKV-NS4B-HA (3 MOI), stained with FLAG- and HA-specific antibodies 
and imaged by confocal microscopy. Boxed areas are enlarged on the right. Graphs on the right-hand 
side of each panel display the mean and standard deviation of Pearson’s correlation coefficients (each 
dot represent 1 cell). Scale bar represents 10 µm. The panel on the right hand (e) Network representation 
of CLN6-interacting cellular proteins and comparison with the ZIKV-NS4B interactors. AP-MS/MS analysis 
of FLAG-tagged CLN6 in SK-N-BE2 cells revealed novel CLN6-specific interacting proteins (displayed in 
magenta; i.e. TELO2 and mTOR) as well as shared cellular interactors with ZIKV-NS4B (displayed in 
yellow, i.e. ICMT, STT3A). Solid lines represent specific interactors identified by AP-MS/MS analysis, grey 
dotted lines represent previously published protein-protein interactions.  
 
 
 Extended Data Figure 5 – Effects of ZIKV infection or NS4B transduction on undifferentiated or 
differentiated hNPC 
(a) Experimental approach used for hNPC differentiation. hNPC cells were transduced with empty (NT), 
HCV-NS4B-HA or ZIKV-NS4B-HA-expressing lentiviruses (MOI=3), mock-infected or infected with ZIKV 
(H/PF/2013) (MOI=0.01). Forty-eight hours later, differentiation was induced for 5 days by growth factor 
withdrawal and addition of 10 µM ROCK inhibitor, while undifferentiated cells were kept in NPC media in 
the presence of bFGF. Cell pellets were next used for quantitative label-free LC-MS/MS-based profiling of 
the global proteome. (b) Characterization of hNPC cells used for proteomic analysis. Undifferentiated 
hNPC kept in the presence of bFGF were stained with (i) SOX2 and GFAP, (ii) Ki67 and MAP2 and (iii) 
Nestin-specific antibodies. Alternatively, hNPC cells differentiated 5 days in the presence of a ROCK 
inhibitor were stained with Ki67 and MAP2-specific antibodies (iv). Under proliferating conditions hNPC 
expressed KI67, SOX2 and NESTIN, confirming maintenance of their proliferative state in the presence of 
FGF. No neuron-specific protein MAP2 or astrocyte marker GFAP were detected under these conditions. 
After differentiation for 5 days in vitro in the presence of ROCK inhibitor, neuronal marker MAP2 was 
upregulated while proliferation marker KI67 was downregulated, suggesting commitment towards the 
neuronal lineage. (c) Cellular processes enriched in NS4B-ZIKV changes in proliferating or differentiating 
hNPC. (d) Total number of proteins identified across biological replicates (n=4) and conditions. (e) Heat 
Map of all significant (p-value ≤ 0.01, |Log2 (Fold-change)| ≥ 1.0) changes occurring upon proliferation 
and differentiation conditions in NS4B-ZIKV transduced cells in comparison to NS4B-HCV and mock 
transduction. 
 
 
 Extended Data Figure 6 – Global proteomic analysis of ZIKV-specific effects in differentiating or 
proliferating hNPC  
(a) hNPC cells were mock-infected or infected with ZIKV (H/PF/2013, MOI=0.01) and cultured under 
proliferating or differentiating conditions as described in Fig. S5a. Volcano plots display proteins 
significantly up- or down-regulated by ZIKV-infection in differentiated (left panel) or undifferentiated (right 
panel) hNPC. Viral proteins are labeled in red. Proteins with functions in antiviral immunity are labeled in 
green. Significance cutoffs are indicated by the dashed grey lines (|Log2 (Fold-change)| ≥ 1; p-
value ≤ 0.01). (b) Venn diagram displaying the total number of significantly up- or down-regulated proteins 
in every experimental condition (|log2 (Fold-change)| ≥ 1; p-value < 0.01) and the total number and gene 
names of significantly modulated proteins similarly regulated by ZIKV infection or ZIKV-NS4B 
transduction upon differentiation (diff) or proliferation (undiff). 
 
 
 Extended Data Figure 7 – Time-resolved phosphoproteomic analysis of ZIKV-infected SK-N-BE2 
cells    
(a) Total number of phosphopeptides, phosphosites and phosphoproteins identified in this study. (b) Total 
number of phosphosites identified across biological replicates and conditions (n=4). (c) Relative 
percentage of Class I, II and III phosphosites (localization probability>0.75) and phosphorylation of 
specific pSer, pThr, pTyr. (d) Venn diagram of significantly changing phosphosites at 24, 48, 72 hours 
post infection. (e) Network analysis of cellular processes significantly modulated by ZIKV infection at 
phosphorylation level (IPA). Nodes are canonical pathways identified with Fisher’s exact test (p-value ≤ 
0.05); edges are shared proteins between the pathways. (f) Profile plots of significantly changing 
phosphosites, mapped to pathways in Fig. 3d, and their corresponding total protein levels at 24, 48 and 
72 hours after ZIKV infection (orange for phospho levels, yellow for protein levels) or mock treatment 
(grey). Numbers next to protein names refer to unique MaxQuant Protein Groups ID (Supplementary 
Table 5). Points are normalized intensities of individual replicates, solid line is median, filled area 
corresponds to 25-75 percentiles, dashed lines mark 2.5-97.5 percentiles of the posterior distribution.  
 
 
 Extended Data Figure 8 – Effect of shRNA-mediated silencing of ZIKV-modulated host proteins on 
viral replication   
(a) Schematic representation of the experimental set-up used for the shRNA screen. Target genes were 
selected among the cellular host factors specifically binding ZIKV-Capsid or -NS4B (Interactome; n=26), 
significantly regulated at the phosphoproteomic level by ZIKV infection (n=6) or significantly regulated at 
the proteomic level both by ZIKV infection and ZIKV-NS4B-expression in hNPC (n=23). Controls included 
non-targeting shRNA of two different pLKO-based lentivirus generations (NT1 and NT2) used as 
reference; and shRNAs targeting the ATP6V0C and Musashi1, which impairs flavivirus pH-dependent 
viral entry and ZIKV replication, respectively 40,41. Two individual shRNAs/gene were selected from the 
MISSION TRC library (Sigma-Aldrich), and used for lentivirus production in 293Ts as described in 
Methods. SK-N-BE2 cells were transduced with individual lentiviruses (3 wells/shRNA) in three 
independent experiments. Three days post-transduction cells were infected with ZIKV H/PF/2013 
(MOI=0.1) and 48 hours later virus-containing supernatants used for titration by PFU assay. The cellular 
viability was assessed with a Resazurin-based assay performed in parallel. (b-c) ZIKV titers and cell 
viability upon knock-down of selected host-factors. Viral titers, as determined by PFU assay, and cell 
viability, as determined by Resazurin assay, are expressed as % of non-targeting controls (n=3). (d) Cell 
viability of SK-N-BE2 cells upon knock-down of selected host factors (n=4, related to Fig. 4b). (e) 
Validation of the silencing efficiency of selected shRNA targeting ZIKV host-factors. The gene silencing 
was evaluated for each cellular protein via Western blot detection using the antibodies specified on the 
right. Asterisks indicate non-specific signal, numbers on the left indicate molecular weight markers 
expressed in kDa.  
 
 Extended Data Figure 9 – Integration of data from orthogonal proteomic screens and protein-
protein interaction databases 
Integrated network of ZIKV protein interactors, CLN6-interacting cellular proteins, proteins changing at 
proteome and/or phosphoproteome levels plus measured or published interactions between them. Baits 
are shown as large red squares. Solid lines represent specific interactions identified by AP-MS/MS 
analysis, grey lines represent published protein-protein interactions from IntAct and CORUM databases. 
Up- or downregulation at the proteome level is marked with filled circles (hNPC: up – red, down – dark 
blue; SK-N-BE2: up – orange, down – light blue). Phosphorylation changes in SK-N-BE2 are presented 
as red (up) or blue (down) circle borders. 
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